Session Details

U032 Lasers & Energy Devices in the Treatment of Acne

Sat, Mar 28, 7:30 AM - 8:30 AM
Mile High 4D
1 CME Available Focus Session Upcoming
View Map

DESCRIPTION

Acne vulgaris is the most common skin disorder in Dermatology. Medical therapy is considered first-line in the treatment of all forms of acne, including inflammatory, comedonal and nodulocystic types. Recently, new technology has been developed to address acne and acne scarring. This session will review the published literature on the various lasers and energy devices used in the treatment of acne vulgaris, along with algorithms that incorporate medical therapies. Safety protocols will be reviewed, including the use of these devices in diverse racial skin types.

LEARNING OBJECTIVES

1.

Discuss the various lasers and energy devices that are available for the treatment of acne.

2.

Select the appropriate laser or energy device for acne patients with diverse skin types.

3.

Describe an algorithm that incorporates lasers/energy devices with medical therapies for acne patients.

SCHEDULE

7:30 AM

Introduction

Valerie D. Callender, MD, FAAD

7:35 AM

Energy-Based Acne Treatments: Expanding the Therapeutic Armamentarium

Glynis R Ablon, MD, FAAD

7:50 AM

Combining Lasers & Energy Devices with Medical Therapies in Acne Management

Valerie D. Callender, MD, FAAD

8:05 AM

Energy Devices & Lasers for Treatment of Acne Scarring

Girish S. Munavalli, MD, MHS, FAAD

8:20 AM

Q&A

DIRECTOR

Valerie D. Callender, MD, FAAD

Valerie D. Callender, MD, FAAD

SPEAKERS

Glynis R Ablon, MD, FAAD

Glynis R Ablon, MD, FAAD

Girish S. Munavalli, MD, MHS, FAAD

Girish S. Munavalli, MD, MHS, FAAD

DISCLOSURES

Glynis R Ablon, MD, FAAD

Benev – Investigator(Grants/Research Funding); Eli Lilly – Investigator(Grants/Research Funding); Galderma Laboratories, L.P. – Investigator(Grants/Research Funding); L'Oreal – Investigator(Grants/Research Funding); Nutrafol – Investigator(Grants/Research Funding);

Valerie D. Callender, MD, FAAD

Aerolase – Advisory Board(Stock Options), Speaker/Faculty Education(Honoraria); Arcutis Biotherapeutics – Speaker(Honoraria); AVAVA, LLC – Investigator(Grants/Research Funding); Beiersdorf, Inc. – Consultant(Honoraria); Cutera – Consultant(Honoraria), Speaker(Honoraria); Eirion Therapeutics – Investigator(Grants/Research Funding); Eli Lilly – Speaker/Faculty Education(Honoraria); Eli Lilly and Company – Investigator(Grants/Research Funding); Erion – Investigator(Grants/Research Funding); Iknow Skincare – Investigator(Grants/Research Funding); janssen – Investigator(Grants/Research Funding); Juenes Aesthetics – Advisory Board(Honoraria); L'Oreal USA Inc. – Consultant(Honoraria), Investigator(Honoraria); La Roche-Posay - L'Oreal Group – Advisory Board(Honoraria); Ortho Dermatologics – Advisory Board(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(No Compensation Received); Prollenium Medical Technologies – Investigator(Grants/Research Funding); Sinclair Pharma – Investigator(Grants/Research Funding); SkinCeuticals LLC – Advisory Board(Honoraria), Speaker(Honoraria); symatese – Investigator(Grants/Research Funding); TEOXANE Laboratories – Investigator(Grants/Research Funding); UpToDate – Other(Patent royalties or other compensation for Intellectual Property Rights); VeraDermics Inc. – Investigator(Grants/Research Funding);

Girish S. Munavalli, MD, MHS, FAAD

AbbVie – Investigator(Grants/Research Funding); Benev – Investigator(Grants/Research Funding); Candela Corporation – Advisory Board(Honoraria); Lumenis – Investigator(Equipment); Sofwave – Investigator(Stock Options);